GBT

Global Blood Therapeutics Inc.

Price

return (12m)

p/e

-13.93

p/bv

37.96

DIVIDEND YIELD

0.00%

GBT price

Global Blood Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment GBT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals GBT

Valuation

P/E

-13.93

Sector -3.50

Industry -3.50

P/BV

37.96

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector 2.01

Industry 2.01

EV/EBITDA

-61.69

Sector -214.99

Industry -214.99

EV/EBIT

-59.75

Sector -47.59

Industry -47.59

P/EBITDA

-13.70

Sector -21.41

Industry -21.41

P/EBIT

-13.33

Sector -28.65

Industry -28.65

P/Total Assets

5.16

Sector 1.19

Industry 1.19

P/Net Current Assets

Sector -11.97

Industry -11.97

P/Working Capital

Sector -167.95

Industry -167.95

EPS

-4.92

Sector -1.81

Industry -1.81

BVPS

1.80

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

44.15%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-103.25%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-106.60%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-100.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.08

Sector 0.02

Industry 0.02

Profitability

ROE

-272.44%

Sector -56.04%

Industry -56.04%

ROA

-37.05%

Sector -60.31%

Industry -60.31%

ROIC

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.89

Industry 2.89

Net Debt / EBITDA

-0.88

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

-0.85

Sector -8.06

Industry -8.06

Net Debt / Equity

0.55

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

4.92

Sector -0.85

Industry -0.85

Equity/Assets

0.14

Sector 0.46

Industry 0.46

Liabilities/Assets

0.14

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

3.82%

Sector -

Industry -

5Y Earnings CAGR

1.25%

Sector -

Industry -

Fundamentals GBT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
GBT Global Blood Therapeutics Inc.	$0.00	-	0.00%	-13.93	37.96	-272.44%	-100.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

GBT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Global Blood Therapeutics

Global Blood Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

15 years

Founded: 2011

2015

Time since IPO - 11 years

352

Employees

Global Blood Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $4.49 billion, with shareholders equity totaling $118.36 million.

The company employs approximately 352 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Global Blood Therapeutics Inc. reported $234.86 million in revenue, generating net income of $-322.46 million.

Key financial metrics include a P/E ratio of -13.93, a price-to-book (P/B) ratio of 37.96, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker GBT.

Market cap

$4.49 billion

Net worth

$118.36 million

$118,360,000.00

Assets

$870.44 million

$870,442,000.00

Total Shares Outstanding

65.59 million

65,594,000

Average Daily Trading Volume

$4.42 million

$4,419,713.90

Sector

Health Care

Industry

Biotechnology

GBT

GBT revenue and profits

Financial Results GBT

DRAG THE FRAME TO SEE MORE DATA

GBT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Global Blood Therapeutics (GBT) today?

A cotação de Global Blood Therapeutics (GBT) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Global Blood Therapeutics (GBT) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Global Blood Therapeutics (GBT) e dados de ações do Ibovespa e mercados internacionais.

Quando Global Blood Therapeutics (GBT) paga dividendos?

Global Blood Therapeutics (GBT) não distribuiu dividendos no último ano.

Is Global Blood Therapeutics (GBT) a good investment?

Atualmente, Global Blood Therapeutics (GBT) está cotada a US$ 0.00, com um P/L de -13.93, representando um desvio de -1,393% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Global Blood Therapeutics (GBT) stock?

Investir em ações de Global Blood Therapeutics (GBT) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Global Blood Therapeutics (GBT) yield today?

A rentabilidade de Global Blood Therapeutics (GBT) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Global Blood Therapeutics (GBT) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

GBT

Global Blood Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment GBT

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING GBT WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Global Blood Therapeutics

Global Blood Therapeutics Inc.

United States

15 years

2015

352

PROFIT X PRICE GBT

Financial Results GBT

GBT cash flow

Asset, Revenue and Profit Growth - GBT

GBT balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions